Cite
HARVARD Citation
Solberg, M. et al. (2020). Gene modification strategies using AO‐mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients. Engineering biology. 4 (3), pp. 37-42. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Solberg, M. et al. (2020). Gene modification strategies using AO‐mediated exon skipping and CRISPR/Cas9 as potential therapies for Duchenne muscular dystrophy patients. Engineering biology. 4 (3), pp. 37-42. [Online].